{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:19:46Z","timestamp":1787242786702,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.medmal.2011.11.001","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T00:45:33Z","timestamp":1323737133000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: Review of international publications"],"prefix":"10.1016","volume":"42","author":[{"given":"J.","family":"Bruxelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pinchinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2011.11.001_bib0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14656566.5.3.551","article-title":"Management of herpes zoster (shingles) and post herpetic neuralgia","volume":"5","author":"Johnson","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.medmal.2011.11.001_bib0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.11.001_bib0015","first-page":"39","article-title":"Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials","volume":"45","author":"Lancaster","year":"1995","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.medmal.2011.11.001_bib0020","first-page":"1","article-title":"Improving the management of varicella herpes zoster and zoster-associated pain. Recommendations from the IHMF management strategies workshop","author":"Johnson","year":"2002","journal-title":"Int Herpes Manag Forum"},{"key":"10.1016\/j.medmal.2011.11.001_bib0025","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.293.6561.1529","article-title":"Oral acyclovir in acute herpes zoster","volume":"293","author":"McKendrick","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.medmal.2011.11.001_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00128071-200506050-00005","article-title":"Current management of herpes zoster: the European view","volume":"6","author":"Volpi","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.medmal.2011.11.001_bib0035","unstructured":"NHS quality improvement Scotland. Evidence note 21: antiviral treatment for shingles and its complications in immunocompetent adults, 2008."},{"key":"10.1016\/j.medmal.2011.11.001_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","article-title":"Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind placebo-controlled trial","volume":"123","author":"Tyring","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2011.11.001_bib0045","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2165\/00003495-200666180-00016","article-title":"Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes","volume":"66","author":"Simpson","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.medmal.2011.11.001_bib0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0166-3542(95)00941-8","article-title":"Famciclovir: review of clinical efficacy and safety","volume":"29","author":"Cirelli","year":"1996","journal-title":"Antiviral Res"},{"key":"10.1016\/j.medmal.2011.11.001_bib0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0924-8579(94)90024-8","article-title":"Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients","volume":"4","author":"Degreef","year":"1994","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2011.11.001_bib0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1386-6532(03)00164-1","article-title":"Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial","volume":"29","author":"Shafran","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.medmal.2011.11.001_bib0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archfami.9.9.863","article-title":"Antiviral therapy for herpes zoster. Randomized controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older","volume":"9","author":"Tyring","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.medmal.2011.11.001_bib0070","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1128\/AAC.38.10.2454","article-title":"Safety of famciclovir in patients with herpes zoster and genital herpes","volume":"38","author":"Saltzman","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2011.11.001_bib0075","first-page":"75","article-title":"Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster","volume":"37","author":"Shen","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.medmal.2011.11.001_bib0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/095632020401500503","article-title":"Recent clinical experience with famciclovir-a \u201cthird generation\u201d nucleoside produg","volume":"15","author":"Chakrabarty","year":"2004","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.medmal.2011.11.001_bib0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/00002512-200320080-00002","article-title":"The role on antivirals in the management of neuropathic pain in the older patient with herpes zoster","volume":"20","author":"Lilie","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.medmal.2011.11.001_bib0090","first-page":"138","article-title":"Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster","volume":"34","author":"Lin","year":"2001","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.medmal.2011.11.001_bib0095","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2011.11.001_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-3542(03)00064-0","article-title":"Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia","volume":"59","author":"Wassilew","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.medmal.2011.11.001_bib0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF03324909","article-title":"Herpes zoster and postherpetic neuralgia: a review of the effects of vaccination","volume":"21","author":"Johnson","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.medmal.2011.11.001_bib0110","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.cger.2007.03.003","article-title":"Herpes zoster and postherpetic neuralgia in older adults","volume":"23","author":"Schmader","year":"2007","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.medmal.2011.11.001_bib0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/bmj.39206.571042.AE","article-title":"Herpes Zoster","volume":"334","author":"Wareham","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.medmal.2011.11.001_bib0120","doi-asserted-by":"crossref","first-page":"s136","DOI":"10.1016\/j.jaad.2007.09.016","article-title":"Management of herpes zoster and postherpetic neuralgia","volume":"57","author":"Tyring","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.medmal.2011.11.001_bib0125","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1016\/j.jpain.2007.10.002","article-title":"Natural history and treatment of herpes zoster","volume":"9","author":"Schmader","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.medmal.2011.11.001_bib0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5694\/j.1326-5377.2008.tb01566.x","article-title":"The prevention and management of herpes zoster","volume":"188","author":"Cunningham","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.medmal.2011.11.001_bib0135","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bmj.326.7392.748","article-title":"Treatment of herpes zoster and postherpetic neuralgia","volume":"326","author":"Johnson","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.medmal.2011.11.001_bib0140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1086\/368196","article-title":"Treatment and prevention of postherpetic neuralgia","volume":"36","author":"Dworkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.11.001_bib0145","first-page":"79","article-title":"Efficacy of oral acyclovir treatment of acute herpes zoster","volume":"85","author":"Wood","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.medmal.2011.11.001_bib0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/02713689109020376","article-title":"Oral acyclovir in herpes zoster ophthalmicus","volume":"10","author":"Harding","year":"1991","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.medmal.2011.11.001_bib0155","first-page":"84","article-title":"Therapy of herpes zoster with oral acyclovir","volume":"85","author":"Huff","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.medmal.2011.11.001_bib0160","first-page":"93","article-title":"Oral acyclovir in the treatment of herpes zoster in general practice","volume":"102","author":"Morton","year":"1989","journal-title":"N Z Med J"},{"key":"10.1016\/j.medmal.2011.11.001_bib0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","article-title":"Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo controlled trials","volume":"22","author":"Wood","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2011.11.001_bib0170","first-page":"62","article-title":"Zoster-associated chronic pain: an overview of clinical trials with acyclovir","volume":"80","author":"Crooks","year":"1991","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.medmal.2011.11.001_bib0175","first-page":"255","article-title":"Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? A systematic review of the literature","volume":"49","author":"Alper","year":"2000","journal-title":"J Fam Pract"},{"key":"10.1016\/j.medmal.2011.11.001_bib0180","first-page":"373","article-title":"Treatment of herpes zoster","volume":"54","author":"Opstelten","year":"2008","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.medmal.2011.11.001_bib0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.1890410518","article-title":"Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis","volume":"Supplement 1","author":"Huff","year":"1993","journal-title":"J Med Virol"},{"key":"10.1016\/j.medmal.2011.11.001_bib0190","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-125-5-199609010-00004","article-title":"Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial","volume":"125","author":"Whitley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2011.11.001_bib0195","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archinte.1997.00440290095010","article-title":"The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia","volume":"157","author":"Jackson","year":"1997","journal-title":"Arch Int Med"},{"key":"10.1016\/j.medmal.2011.11.001_bib0200","series-title":"Antiviral treatment for preventing postherpetic neuralgia. The Cochrane collaboration","author":"Li","year":"2009"},{"key":"10.1016\/j.medmal.2011.11.001_bib0205","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/514260","article-title":"Impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients","volume":"178","author":"Dworkin","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2011.11.001_bib0275","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.respe.2010.06.166","article-title":"Burden of Herpes Zoster and postherpetic neuralgia: incidence, proportion, and associated costs in the French population aged 50 or over","volume":"58","author":"Mick","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.medmal.2011.11.001_bib0215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/875512250402000405","article-title":"Valacyclovir and postherpetic neuralgia","volume":"20","author":"Segarra-Newnham","year":"2004","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.medmal.2011.11.001_bib0220","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14656560902808502","article-title":"The treatment of varicella-zoster virus infection and its complications","volume":"10","author":"Partridge","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.medmal.2011.11.001_bib0225","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Herpes Zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2011.11.001_bib0230","first-page":"63","article-title":"Pain following herpes zoster: implications for management","volume":"11","author":"Johnson","year":"2004","journal-title":"Herpes"},{"key":"10.1016\/j.medmal.2011.11.001_bib0235","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/514271","article-title":"Treatment of acute herpes zoster: effect of early (<48h) versus Late (48\u201372h) therapy with acyclovir and valaciclovir","volume":"178","author":"Wood","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2011.11.001_bib0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1468-3083.2000.00020.x","article-title":"Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir","volume":"14","author":"Decroix","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.medmal.2011.11.001_bib0245","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/147323000203000109","article-title":"Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster","volume":"30","author":"Kurokawa","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1016\/j.medmal.2011.11.001_bib0250","first-page":"38","article-title":"Herpes zoster in the immunocompetent patient: management of post-herpetic neuralgia","volume":"10","author":"Johnson","year":"2003","journal-title":"Herpes"},{"key":"10.1016\/j.medmal.2011.11.001_bib0255","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1001\/jama.2009.1580","article-title":"Postherpetic neuralgia in herpes zoster","volume":"302","author":"Zhou","year":"2009","journal-title":"J Am Med Assoc"},{"issue":"RR\u20135","key":"10.1016\/j.medmal.2011.11.001_bib0260","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.medmal.2011.11.001_bib0265","unstructured":"Wood MJ, Kroon S. Reducing the burden of Zoster-associated pain. Int Herpes Manag Forum, 1997."},{"key":"10.1016\/j.medmal.2011.11.001_bib0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4414\/smw.2007.11721","article-title":"Swiss recommendations for the management of varicella zoster virus infections","volume":"137","author":"Kempf","year":"2007","journal-title":"Swiss Med Wkly"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X11003556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X11003556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:10:25Z","timestamp":1759972225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X11003556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0399077X11003556"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2011.11.001","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: Review of international publications","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2011.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}